Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial

Dalziel, SR; Borland, ML; Furyk, Jeremy; Bonisch, M; Neutze, J; Donath, S; Francis, KL; Sharpe, C; Harvey, AS; Davidson, A; Craig, S; Phillips, N; George, S; Rao, A; Cheng, N; Zhang, M; Kochar, A; Brabyn, C; Oakley, E; Babl, FE

Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial

journal contribution

posted on 2024-06-05, 04:05 authored by SR Dalziel, ML Borland, Jeremy FurykJeremy Furyk, M Bonisch, J Neutze, S Donath, KL Francis, C Sharpe, AS Harvey, A Davidson, S Craig, N Phillips, S George, A Rao, N Cheng, M Zhang, A Kochar, C Brabyn, E Oakley, FE Babl

Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial

History

Journal

The Lancet

Volume

393

Pagination

2135-2145

Location

London, Eng.

ISSN

0140-6736

eISSN

1474-547X

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Issue

10186

Publisher

The Lancet Publishing Group

Usage metrics

Keywords

3202 Clinical sciences 4203 Health services and systems

Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial

History

Journal

Volume

Pagination

Location

ISSN

eISSN

Language

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports